Evidence map›Paper›PMID 36547133›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Jonathan Jun Kit Liow, Zi Lin Lim, Tomiko Mei Ying Sim, Peh Joo Ho, Su-Ann Goh, Sheen Dian Choy, Ying Jia Chew, Benita Kiat-Tee Tan, Veronique Kiak Mien Tan, Mikael Hartman and 2 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Risk-Stratified Breast Cancer Screening in Malaysia: Challenges and Opportunities.Asian Pacific journal of cancer prevention : APJCP · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jonathan Jun Kit LiowLaboratory of Women's Health and Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore.
Zi Lin LimLaboratory of Women's Health and Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore.ORCID 0000-0001-7854-8728
Tomiko Mei Ying SimLaboratory of Women's Health and Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore.
Peh Joo HoLaboratory of Women's Health and Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore.ORCID 0000-0002-3017-4023
Su-Ann GohSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117549, Singapore.
Sheen Dian ChoyHuman Development, Singapore Institute for Clinical Sciences, A*STAR Research Entities, Singapore 117609, Singapore.
Ying Jia ChewDepartment of General Surgery, Ng Teng Fong General Hospital, Singapore 609606, Singapore.
Benita Kiat-Tee TanSingHealth Duke-NUS Breast Centre, Singapore 168582, Singapore.
Veronique Kiak Mien TanSingHealth Duke-NUS Breast Centre, Singapore 168582, Singapore.
Mikael HartmanDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 117597, Singapore.
Keri McCrickerdHuman Development, Singapore Institute for Clinical Sciences, A*STAR Research Entities, Singapore 117609, Singapore.ORCID 0000-0003-3171-7584
Jingmei LiLaboratory of Women's Health and Genetics, Genome Institute of Singapore, A*STAR, Singapore 138672, Singapore.ORCID 0000-0001-8587-7511

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Singapore launched a population-based organised mammography screening (MAM) programme in 2002. However, uptake is low. A better understanding of breast cancer (BC) risk factors has generated interest in shifting from a one-size-fits-all to a risk-based screening approach. However, public acceptability of the change is lacking. Focus group discussions (FGD) were conducted with 54 women (median age 37.5 years) with no BC history. Eight online sessions were transcribed, coded, and thematically analysed. Additionally, we surveyed 993 participants in a risk-based MAM study on how they felt in anticipation of receiving their risk profiles. Attitudes towards MAM (e.g., fear, low perceived risk) have remained unchanged for ~25 years. However, FGD participants reported that they would be more likely to attend routine mammography after having their BC risks assessed, despite uncertainty and concerns about risk-based screening. This insight was reinforced by the survey participants reporting more positive than negative feelings before receiving their risk reports. There is enthusiasm in knowing personal disease risk but concerns about the level of support for individuals learning they are at higher risk for breast cancer. Our results support the empowering of Singaporean women with personal health information to improve MAM uptake.

Indexed as

Breast NeoplasmsAdultEarly Detection of CancerFemaleFocus GroupsHealth Knowledge, Attitudes, PracticeHumansRisk Assessmentbreast cancerfocus group discussiongenetic literacyhealth behaviourhealth consciousnessmammography screeningprecision healthqualitative researchrisk-based screening

Identifiers

PMID36547133
PMCPMC9776908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.